Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.2B | 1.3B | 1.2B | 1.2B |
Cost of revenue | 786M | 857M | 789M | 791M |
Gross profit | 387M | 415M | 371M | 423M |
Operating expense | ||||
Research & development | 24M | 30M | 25M | 24M |
Selling general and admin | 199M | 204M | 188M | 193M |
Other operating expenses | -6M | 15M | -19M | 10M |
Operating income | 170M | 166M | 177M | 196M |
Non operating interest income | ||||
Income | 4M | 5M | 5M | 5M |
Expense | 21M | 28M | 25M | 21M |
Other income expense | — | — | — | — |
Pretax income | 154M | 143M | 160M | 180M |
Tax provision | 40M | 39M | 37M | 45M |
Net income | 119M | 158M | -79M | 129M |
Basic EPS | 0.1 | 0.2 | -0.1 | 0.2 |
Diluted EPS | 0.1 | 0.2 | -0.1 | 0.2 |
Basic average shares | 827.4M | 831.6M | 866.7M | 800M |
Diluted average shares | 827.4M | 831.6M | 866.7M | 800M |
EBITDA | 219M | 213M | 226M | 241M |
Net income from continuing op. | 119M | 158M | -79M | 129M |
Minority interests | 0 | 0 | 0 | -1M |
Preferred stock dividends | 0 | 0 | 0 | 0 |